Ranibizumab in Diabetic Vitrectomy. A Prospective, Randomised Controlled Trial of Ranibizumab Pre-treatment in Diabetic Vitrectomy - a Pilot Study

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 30, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

March 12, 2013

Conditions

Diabetic RetinopathyRetinal Neovascularisation

Interventions

DRUG

Ranibizumab

Intravitreal injection of ranibizumab, 0.5mg in 0.05ml

DRUG

Saline

Subconjunctival injection of 0.05ml saline 0.9% w/v

Trial Locations (1)

Moorfields Eye Hospital, London